Fourth Community Pharmacy Agreement Evaluation Reports

The reports on the evaluations of programs under the Fourth Community Pharmacy Agreement.

Page last updated: 10 June 2011

The five year Sixth Community Pharmacy Agreement (6CPA) between the Commonwealth of Australia and the Pharmacy Guild of Australia commenced on 1 July 2015 and is a key element of the PBS Access and Sustainability Package, announced in the 2015-16 Budget. Further information about the 6CPA can be found on the PBS website.


As part of the Fourth Community Pharmacy Agreement a number of professional programs and services were delivered.

Evaluations of programs and the Professional Programs and Services Advisory Committee were completed and the reports are available below:
The Quality Use of Medicines Maximised for Aboriginal and Torres Strait Islander Peoples (QUMAX) Program Evaluation

The Quality Use of Medicines Maximised for Aboriginal and Torres Strait Islander Peoples (QUMAX) Program began as a two year trial commencing in 2008 under the Fourth Community Pharmacy Agreement and was subsequently extended for a transitional year. The QUMAX Program focussed on trialling a number of activities to address the known barriers to accessing PBS medicines in non-remote Aboriginal and Torres Strait Islander communities.

The results of the QUMAX evaluation indicate that the program has been successful in:
  • achieving key program objectives of improving access to PBS medicines, and supporting medication compliance and quality use of medicines for Aboriginal and Torres Strait Islander peoples in rural and urban areas of Australia; and
  • trialling a number of activities to address barriers to accessing PBS medicines in non-remote Aboriginal and Torres Strait Islander communities.
PDF printable version for The Quality Use of Medicines Maximised for Aboriginal and Torres Strait Islander Peoples (QUMAX) Program Evaluation (PDF 1962 KB)
Top of page